Применение мелаксена на фоне базисного лечения при терапии хронического алкогольного гепатита в стадии обострения

Sergey Sergeevich Popov, А. Н. Пашков, И. Э. Есауленко et al. · Вестник новых медицинских технологий · 2013

After carrying out of the basic treatment in the patients with a chronic alcoholic hepatitis, the improvement of the general state is noted in the 56,2% of patients. Change of biochemical parameters characterizing severity of pathological process to the side of norm was observed. The combined therapy by Melaxen affected more favorably on biochemical indicators and the general state improved in the 64,5% of patients. It is established the reduction of dien conjugates level and catalase activity in comparison with basis treatment due to decrease of degree of oxidative stress development caused by Melaxen antiradical action. Side-effect of the Melaxen use on the background of base therapy of chronic alcoholic hepatitis was not observed.

Cited by 0 works.

Authors